Microbiology Spectrum · 2022 · 10 citations · 41 references
Life SciencesInfectious DiseasesMolecular BiologyImmunotechnologyMolecular VirologyVirologyInfectious Disease Molecular TestingRna-based DiagnosticsDiagnostic Assay DevelopmentNetwork TestingPcr-based DetectionRapid Antigen Detection TestingRapid Antigen TestingViral Antigen Detection
Pandemic mitigation requires continuous testing of symptomatic or asymptomatic individuals with rapid turnaround time, and lack of this capability in our community has prolonged pandemic duration leading to obliteration of world economies. The DxCell platform is a cell-based self-replicative antigen test that detects molecular signatures of the target pathogen and can be distributed in small quantities to testing facilities for expansion on site to the desired volume. In this work, we directed this platform to target SARS-CoV-2. Unlike the PCR detection of viral mRNA that requires trained personnel, the DxCell does not require any sample preparation or signal amplification step and introduces an opportunity for a decentralized testing network.
41
Global trends in emerging infectious diseases
Kate E. Jones, Nikkita Patel, Marc A. Levy et al. · Nature · 2008 · 8.3K citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +14
Presumed Asymptomatic Carrier Transmission of COVID-19
Yan Bai, Tao Wei, Fei Tian et al. · JAMA · 2020 · 4.9K citations · Full text
Veterinary Medicine, Infectious Diseases, Infectious Disease Epidemiology +10
CRISPR–Cas12-based detection of SARS-CoV-2
James P. Broughton, Xianding Deng, Guixia Yu et al. · Nature Biotechnology · 2020 · 2.8K citations · Full text
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto, Young‐Jun Park, Martina Beltramello et al. · Nature · 2020 · 2.2K citations · Full text